The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women.
To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.
Pregnant women or parturient women confirmed by blood HCG test.
Patients aged 18 years old and above.
Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.
Patients without valid telephone numbers.
Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.
Pregnant women who had an antenatal visit or gave birth between 2014 and 2023.
Cohort
Retrospective
Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C
Procedure/SurgeryInitiated Standard DAA treatment among HCV RNA positive patients.
Relink rate
The percentage of patients receiving DAA treatment among the diagnosed but untreated patients.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
